JP2024540994A5 - - Google Patents
Info
- Publication number
- JP2024540994A5 JP2024540994A5 JP2024524371A JP2024524371A JP2024540994A5 JP 2024540994 A5 JP2024540994 A5 JP 2024540994A5 JP 2024524371 A JP2024524371 A JP 2024524371A JP 2024524371 A JP2024524371 A JP 2024524371A JP 2024540994 A5 JP2024540994 A5 JP 2024540994A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- cytoplasmic
- inhibitor
- sensing inhibitor
- nanoparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163203451P | 2021-07-23 | 2021-07-23 | |
| US63/203,451 | 2021-07-23 | ||
| PCT/US2022/074084 WO2023004437A1 (en) | 2021-07-23 | 2022-07-22 | Method of enhancing gene therapy by targeting cgas-sting pathway |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540994A JP2024540994A (ja) | 2024-11-06 |
| JP2024540994A5 true JP2024540994A5 (https=) | 2025-07-25 |
Family
ID=84980517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524371A Pending JP2024540994A (ja) | 2021-07-23 | 2022-07-22 | 非ウイルス性ｄｎａ送達のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240350667A1 (https=) |
| EP (1) | EP4373946A4 (https=) |
| JP (1) | JP2024540994A (https=) |
| KR (1) | KR20240083170A (https=) |
| CN (1) | CN117980487A (https=) |
| AU (1) | AU2022316228A1 (https=) |
| CA (1) | CA3230386A1 (https=) |
| CO (1) | CO2024002065A2 (https=) |
| IL (1) | IL311167A (https=) |
| WO (1) | WO2023004437A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024054901A1 (en) * | 2022-09-09 | 2024-03-14 | Spark Therapeutics, Inc. | Piperazine compounds |
| CN117682973B (zh) * | 2022-09-26 | 2026-03-20 | 中国药科大学 | 磺酰胺类化合物及其医药用途 |
| WO2025265081A1 (en) * | 2024-06-21 | 2025-12-26 | Stylus Medicine, Inc. | cGAS-STING PATHWAY INHIBITORS AND USES THEREOF |
| CN118908937B (zh) * | 2024-07-10 | 2025-07-15 | 中山大学中山眼科中心 | 一种具有sting蛋白降解作用的化合物及其制备方法和用途 |
| CN119185549B (zh) * | 2024-10-25 | 2025-09-02 | 四川大学华西医院 | Sting抑制剂在制备治疗或预防心脏骤停后综合征药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130037977A1 (en) * | 2010-04-08 | 2013-02-14 | Paul A. Burke | Preparation of Lipid Nanoparticles |
| EP2934598B1 (en) * | 2012-12-19 | 2018-04-18 | Board Of Regents, The University Of Texas System | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway |
| JP2022518504A (ja) * | 2019-01-24 | 2022-03-15 | ジェネレーション バイオ カンパニー | 閉端ｄｎａ（ｃｅｄｎａ）ならびに遺伝子療法または核酸療法に関連する免疫応答を低減させる方法における使用 |
| EP4061403A4 (en) * | 2019-11-19 | 2023-12-27 | Spark Therapeutics, Inc. | Secretable protein induced immune tolerization and treatment of autoimmune, allergic and other diseases and disorders |
-
2022
- 2022-07-22 JP JP2024524371A patent/JP2024540994A/ja active Pending
- 2022-07-22 US US18/685,681 patent/US20240350667A1/en active Pending
- 2022-07-22 CA CA3230386A patent/CA3230386A1/en active Pending
- 2022-07-22 AU AU2022316228A patent/AU2022316228A1/en active Pending
- 2022-07-22 KR KR1020247006154A patent/KR20240083170A/ko active Pending
- 2022-07-22 WO PCT/US2022/074084 patent/WO2023004437A1/en not_active Ceased
- 2022-07-22 CN CN202280063892.2A patent/CN117980487A/zh active Pending
- 2022-07-22 IL IL311167A patent/IL311167A/en unknown
- 2022-07-22 EP EP22846872.4A patent/EP4373946A4/en active Pending
-
2024
- 2024-02-23 CO CONC2024/0002065A patent/CO2024002065A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540994A5 (https=) | ||
| US10709797B2 (en) | Isolation of extracellular vesicles (EVs) from red blood cells for gene therapy | |
| JP6924744B2 (ja) | Ｂ型肝炎ウイルスに対する組成物および薬剤ならびにその使用 | |
| US8853177B2 (en) | Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto | |
| CN103333890B (zh) | 治疗乙型病毒性肝炎的rna干扰制剂 | |
| JP2021504445A (ja) | エプスタイン−バーウイルスワクチン | |
| JP2019532080A5 (https=) | ||
| CN104220599A (zh) | 人工核酸分子 | |
| JP2022132605A5 (https=) | ||
| US9534219B2 (en) | Methods of treating vascular inflammatory disorders | |
| TW201408309A (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| EP3898942A1 (en) | Nanoparticle compositions for efficient nucleic acid delivery and methods of making and using the same | |
| US12234455B2 (en) | Therapeutic oligonucleotides | |
| US20220305118A1 (en) | Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines | |
| US11564884B2 (en) | Cationic block polymer micelles for delivery of biological agents | |
| WO2018193902A1 (ja) | マイクロｒｎａによるｂ型肝炎ウイルスに対する抗ウイルス効果 | |
| KR102156324B1 (ko) | 핵산 복합체를 유효성분으로 함유하는 혈관신생관련 질환 치료용 약학 조성물 | |
| KR20110139743A (ko) | 모균증 및 다른 진균 질환의 치료를 위한 백신 조성물 및 방법 | |
| WO2016061549A1 (en) | Compositions comprising small interfering rna molecules for prevention and treatment of ebola virus disease | |
| CN118043461A (zh) | 方法 | |
| WO2014195693A1 (en) | Prevention and treatment of atrial fibrillation | |
| US20210198629A1 (en) | Compositions and methods for increasing beiging of white adipose tissue | |
| WO2013088853A1 (ja) | オリゴヌクレオチド、グルココルチコイド感受性増強剤、医薬組成物、及び発現ベクター | |
| WO2023237726A1 (en) | An intracellular tumor-specific variant of human zona pellucida glycoprotein 3 and nucleic acids coding therefor for use in the treatment of cancer | |
| US20240318147A1 (en) | Recombinant oncolytic virus, and construction method therefor and use thereof |